Recent studies indicate that the coronavirus is triggering many new autoimmune and neurological diseases. That's good news for chronic fatigue syndrome (ME/CFS)
Anticoagulant and anti-platelet therapy reduces symptoms significantly in long COVID. The implications for chronic fatigue syndrome (ME/CFS), fibromyalgia and POTS are discussed.
An innovative gene expression study suggests that an immune cell that's hardly been studied in chronic fatigue syndrome - monocytes - could be the prime driver of the immune problems in the disease.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.